Use of chronic medications and risk of severe death due to COVID-19 in hospitalised patients.

María Larrosa-GarcíaSonia Garcia-GarciaJavier LouroAdrián Sánchez-MontalváJulia Sampol SirventSalvador Augustín RecioAlfredo Guillén Del CastilloJudit Riera-ArnauMaria Queralt GorgasMarta Miarons

Published in: European journal of hospital pharmacy : science and practice (2022)

This study investigated the association between chronic exposure to drugs and the risk of death in COVID-19 patients. Our results have shed some light on the impact of chronic drug exposure on the risk of severe COVID-19; however, further research is needed to increase the understanding about its relevance.

Keyphrases

sars cov
coronavirus disease
drug induced
end stage renal disease
newly diagnosed
early onset
ejection fraction
chronic kidney disease
peritoneal dialysis
respiratory syndrome coronavirus
patient reported outcomes
patient reported
adverse drug